Longitudinal aortic strain, ventriculo-arterial coupling and fatty acid oxidation: novel insights into human cardiovascular aging.
Hongzhou ZhangShuang LengFei GaoJean-Paul KovalikRu-San TanHai Ning WeeKee Voon ChuaJianhong ChingXiaodan ZhaoJohn AllenQinghua WuTim LeinerLiang ZhongAngela S KohPublished in: GeroScience (2024)
Aging-induced aortic stiffness has been associated with altered fatty acid metabolism. We studied aortic stiffness using cardiac magnetic resonance (CMR)-assessed ventriculo-arterial coupling (VAC) and novel aortic (AO) global longitudinal strain (GLS) combined with targeted metabolomic profiling. Among community older adults without cardiovascular disease, VAC was calculated as aortic pulse wave velocity (PWV), a marker of arterial stiffness, divided by left ventricular (LV) GLS. AOGLS was the maximum absolute strain measured by tracking the phasic distance between brachiocephalic artery origin and aortic annulus. In 194 subjects (71 ± 8.6 years; 88 women), AOGLS (mean 5.6 ± 2.1%) was associated with PWV (R = -0.3644, p < 0.0001), LVGLS (R = 0.2756, p = 0.0001) and VAC (R = -0.3742, p <0.0001). Stiff aorta denoted by low AOGLS <4.26% (25 th percentile) was associated with age (OR 1.13, 95% CI 1.04-1.24, p = 0.007), body mass index (OR 1.12, 95% CI 1.01-1.25, p = 0.03), heart rate (OR 1.04, 95% CI 1.01-1.06, p = 0.011) and metabolites of medium-chain fatty acid oxidation: C8 (OR 1.005, p = 0.026), C10 (OR 1.003, p = 0.036), C12 (OR 1.013, p = 0.028), C12:2-OH/C10:2-DC (OR 1.084, p = 0.032) and C16-OH (OR 0.82, p = 0.006). VAC was associated with changes in long-chain hydroxyl and dicarboxyl carnitines. Multivariable models that included acyl-carnitine metabolites, but not amino acids, significantly increased the discrimination over clinical risk factors for prediction of AOGLS (AUC [area-under-curve] 0.73 to 0.81, p = 0.037) and VAC (AUC 0.78 to 0.87, p = 0.0044). Low AO GLS and high VAC were associated with altered medium-chain and long-chain fatty acid oxidation, respectively, which may identify early metabolic perturbations in aging-associated aortic stiffening. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02791139.
Keyphrases
- aortic valve
- left ventricular
- fatty acid
- pulmonary artery
- aortic dissection
- heart rate
- cardiovascular disease
- magnetic resonance
- aortic stenosis
- transcatheter aortic valve replacement
- blood pressure
- body mass index
- heart failure
- acute myocardial infarction
- hydrogen peroxide
- physical activity
- ms ms
- hypertrophic cardiomyopathy
- cardiac resynchronization therapy
- endothelial cells
- mitral valve
- coronary artery
- cross sectional
- healthcare
- type diabetes
- clinical trial
- dendritic cells
- heart rate variability
- mental health
- left atrial
- percutaneous coronary intervention
- high glucose
- drug delivery
- pregnant women
- diabetic rats
- room temperature
- polycystic ovary syndrome
- amino acid
- drug induced
- insulin resistance
- oxidative stress
- weight gain
- ejection fraction
- immune response
- contrast enhanced
- coronary artery disease